BiomX (PHGE) Investor presentation summary

Strategic repositioning and business model

• Shifted from clinical-stage biotechnology to focus on advanced threat detection for defense and security markets.

• Technologies are deployed across defense, security, transportation, and critical infrastructure sectors.

• Emphasizes a portfolio approach: detection, analysis, and coordinated response.

• Acquires specialized companies to address emerging security gaps faster than large defense primes.

• Prioritizes acquisition targets with field-proven, defense-relevant technologies that fit its architecture.

Portfolio and technology highlights

• Zorronet: AI-based autonomous C5ISR platform for real-time data fusion, event prioritization, and operational response.

• DFSL: Proprietary LADAR detection systems for UAV, border, and perimeter security, with high accuracy and low false alarms.

• Portfolio covers detection (DFSL), analysis (Zorronet), and response, enabling integrated threat mitigation.

• DFSL's LADAR offers 360° surveillance, all-weather operation, and minimal infrastructure requirements.

• Zorronet connects cameras, sensors, and systems into an AI-enabled command-and-control layer.

Market opportunities and deployments

• Addresses high-growth markets: counter-UAS, perimeter security, AI command-and-control, video analytics, and critical infrastructure protection.

• Market sizes range from $3.3B (emergency response) to $197.3B (critical infrastructure protection) by 2030.

• Technologies validated through deployments with IDF, Elbit Systems, Rafael, Israel Railways, and international partners.

• Active in U.S., Mexico, Israel, UAE, and European security programs.